3D cell culture is a technique in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Besides, the ability of 3D cell culture to provide more physiologically relevant information and more accurate data in vivo tests has led 3D cell culture systems to become acceptable in comparison to 2D Cell culture. Many factors drive the market of 3D cell culture across the world such as an advanced technique in organ and tissue regeneration, provide drug toxicology screening and many more.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5928
The global 3D cell culture market has been identified as one of the fastest growing industries, owing to the varying applications of 3D cell culture in biotech and pharmaceutical industry and rising prevalence of cancer worldwide, rising approval from government bodies, and growing awareness Increasing incidence of cancer and rising demand for organs transplantation due to increasing prevalence of organ failures has majorly influenced the growth of the market.
The global 3D cell culture market share is expected to grow at a CAGR of 25.50% during the forecast period 2017–2023.
Segmentation
The global 3D cell culture market is segmented on the basis of technique, product, application, and end-user. On the basic technique, it is segmented into Scaffolds Based 3D Cell Culture and Scaffold-Free 3D Cell Culture. On the basis of the product, it is segmented into Consumables and Instruments. On the basis of the application, it is segmented into cancer research, stem cell research, drug discovery, Tissue Screening & Engineering, Regenerative Medicine and others. On the basis of the end users, it is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Research & Academic Laboratories and others.
Key Findings
- The global 3D cell culture market was USD 725.15 million in 2016
- Consumables are the largest segment, by product which is projected to grow at a CAGR of 25.88% during the forecast period from 2017–2023
- Drug discovery is the largest segment, by application for the global 3D cell culture and expected to grow at a rate of CAGR 25.75% during the forecast period
- The Pharmaceutical & Biotechnology Companies segment and is expected grow with the CAGR of 26.13% for the forecast period.
Regional Analysis
Global 3D cell culture, on the basis of region, the market is divided into the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas accounted for the largest market share of for global 3D cell culture market. This large share is majorly attributed due to the presence of major manufacturers, high rate of cancer among the population, rising need for organ donation, and various others. Europe accounts for the second largest market share, whereas Asia Pacific is expected to grow at the fastest rate with 26.17% CAGR for the forecast period. With lots of opportunity and continuously growing economies, the region is expected to be the fastest growing segment. Factors such as recent healthcare developments, improving economies, high aging population, and increased healthcare spending are influencing the growth of the market. The Middle East & Africa with less economic developments and extremely low income accounted for the least market share in 2016 but is expected to grow in coming future.
Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/3d-cell-culture-market-5928
No comments:
Post a Comment